NA

Nacho Aguilo

Department of Microbiology, University of Zaragoza

Affiliated withUniversity of Zaragoza

Research Area

Immunology and Infection

Biography

Nacho Aguilo has not added Biography.
If you are Nacho Aguilo and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 14	2016

Other Publications

Article	Year
Recent developments in tuberculosis vaccines. Expert review of vaccines\| PubMed ID: 24195481	2013
ESX-1-induced apoptosis during mycobacterial infection: to be or not to be, that is the question. Frontiers in cellular and infection microbiology\| PubMed ID: 24364000	2013
Pulmonary Mycobacterium bovis BCG vaccination confers dose-dependent superior protection compared to that of subcutaneous vaccination. Clinical and vaccine immunology : CVI\| PubMed ID: 24501340	2014
A human dendritic cell-based in vitro model to assess Mycobacterium tuberculosis SO2 vaccine immunogenicity. ALTEX\| PubMed ID: 24840067	2014
A specific polymorphism in Mycobacterium tuberculosis H37Rv causes differential ESAT-6 expression and identifies WhiB6 as a novel ESX-1 component. Infection and immunity\| PubMed ID: 24891105	2014
Elucidating sources and roles of granzymes A and B during bacterial infection and sepsis. Cell reports\| PubMed ID: 25017060	2014
Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice. Vaccine\| PubMed ID: 25066740	2014
Mouse cytotoxic T cell-derived granzyme B activates the mitochondrial cell death pathway in a Bim-dependent fashion. The Journal of biological chemistry\| PubMed ID: 25605735	2015
Human NK cells activated by EBV(+) lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells. Oncoimmunology\| PubMed ID: 25949911	2015
Klebsiella pneumoniae survives within macrophages by avoiding delivery to lysosomes. Cellular microbiology\| PubMed ID: 26045209	2015
Pulmonary but Not Subcutaneous Delivery of BCG Vaccine Confers Protection to Tuberculosis-Susceptible Mice by an Interleukin 17-Dependent Mechanism. The Journal of infectious diseases\| PubMed ID: 26494773	2016
Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial. The Lancet. Respiratory medicine\| PubMed ID: 26598141	2015
Evaluation of the immunogenicity and diagnostic interference caused by M. tuberculosis SO2 vaccination against tuberculosis in goats. Research in veterinary science\| PubMed ID: 26679799	2015
MTBVAC vaccine is safe, immunogenic and confers protective efficacy against Mycobacterium tuberculosis in newborn mice. Tuberculosis (Edinburgh, Scotland)\| PubMed ID: 26786657	2016
Granzyme A Is Expressed in Mouse Lungs during Mycobacterium tuberculosis Infection but Does Not Contribute to Protection In Vivo. PloS one\| PubMed ID: 27055232	2016

Copyright © 2026 MyJoVE Corporation. All rights reserved.